These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 10771610

  • 1. [Effects of human papilloma virus types on course of juvenile respiratory papillomatosis and effectiveness of interferon therapy in children].
    Nurmukhametov RKh, Onufrieva EK, Soldatskiĭ IuL, Brodskiĭ MIu.
    Vestn Otorinolaringol; 2000; (2):37-40. PubMed ID: 10771610
    [Abstract] [Full Text] [Related]

  • 2. Virological and immunological aspects in the juvenile laryngeal papillomatosis.
    Gheorghe DC, Ardelean C, Anton G.
    Rom J Virol; 1999; 50(1-4):85-9. PubMed ID: 11601383
    [Abstract] [Full Text] [Related]

  • 3. Current advances in the basic research and clinical management of juvenile-onset recurrent respiratory papillomatosis.
    Bergler WF, Götte K.
    Eur Arch Otorhinolaryngol; 2000; 257(5):263-9. PubMed ID: 10923940
    [Abstract] [Full Text] [Related]

  • 4. [Prevalence of human papilloma virus types and their influence on the course of the disease in children suffering from recurrent respiratory papillomatosis].
    Obchinnikov IuM, Kiselev VI, Soldatskiĭ IuL, Artem'ev MI, Onufrieva EK, Baranovskiĭ PM, Shchepin NV, Smetanina SE, Gasparian SF, Steklov AM.
    Vestn Otorinolaringol; 2004; (3):29-33. PubMed ID: 15159735
    [Abstract] [Full Text] [Related]

  • 5. Changes in human papillomavirus typing of recurrent respiratory papillomatosis progressing to malignant neoplasm.
    Doyle DJ, Henderson LA, LeJeune FE, Miller RH.
    Arch Otolaryngol Head Neck Surg; 1994 Nov; 120(11):1273-6. PubMed ID: 7917213
    [Abstract] [Full Text] [Related]

  • 6. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease.
    Rabah R, Lancaster WD, Thomas R, Gregoire L.
    Pediatr Dev Pathol; 2001 Nov; 4(1):68-72. PubMed ID: 11200493
    [Abstract] [Full Text] [Related]

  • 7. [Virologic aspects of juvenile laryngeal papillomatosis].
    Major T, Jókay I, Soós G, Gergely L, Czeglédy J.
    Orv Hetil; 1999 Feb 21; 140(8):405-9. PubMed ID: 10083813
    [Abstract] [Full Text] [Related]

  • 8. Pharmacotherapy of recurrent respiratory papillomatosis: an expert opinion.
    Gallagher TQ, Derkay CS.
    Expert Opin Pharmacother; 2009 Mar 21; 10(4):645-55. PubMed ID: 19284366
    [Abstract] [Full Text] [Related]

  • 9. [Clinical and molecular biology studies of respiratory papillomatosis].
    Mahnke CG, Werner JA, Fröhlich O, Lippert BM, Hoffmann M, Rudert HH.
    Laryngorhinootologie; 1998 Mar 21; 77(3):157-64. PubMed ID: 9577823
    [Abstract] [Full Text] [Related]

  • 10. E6 and E7 oncogene expression by human papilloma virus (HPV) and the aggressive behavior of recurrent laryngeal papillomatosis (RLP).
    Shehata BM, Otto KJ, Sobol SE, Stockwell CA, Foulks C, Lancaster W, Gregoire L, Hill CE.
    Pediatr Dev Pathol; 2008 Mar 21; 11(2):118-21. PubMed ID: 17990904
    [Abstract] [Full Text] [Related]

  • 11. Assessment of human papilloma virus infection in adult laryngeal papilloma using a screening test.
    Makiyama K, Hirai R, Matsuzaki H, Ikeda M.
    J Voice; 2013 Mar 21; 27(2):230-5. PubMed ID: 23273988
    [Abstract] [Full Text] [Related]

  • 12. HPV types causing juvenile recurrent laryngeal papillomatosis in South Africa.
    Seedat RY, Thukane M, Jansen AC, Rossouw I, Goedhals D, Burt FJ.
    Int J Pediatr Otorhinolaryngol; 2010 Mar 21; 74(3):255-9. PubMed ID: 20018386
    [Abstract] [Full Text] [Related]

  • 13. [Clinical and molecular biology studies of laryngeal papillomatosis].
    Mahnke CG, Werner JA, Fröhlich O, Lippert BM, Hoffman H, Rudert HH.
    Laryngorhinootologie; 1998 Jan 21; 77(1):27-33. PubMed ID: 9522309
    [Abstract] [Full Text] [Related]

  • 14. Juvenile-onset recurrent respiratory papillomatosis involving the lung: A case report and review of the literature.
    Magid MS, Chen YT, Soslow RA, Boulad F, Kernan NA, Szabolcs P.
    Pediatr Dev Pathol; 1998 Jan 21; 1(2):157-63. PubMed ID: 9507042
    [No Abstract] [Full Text] [Related]

  • 15. Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up.
    Gerein V, Rastorguev E, Gerein J, Jecker P, Pfister H.
    Ann Otol Rhinol Laryngol; 2005 Jun 21; 114(6):463-71. PubMed ID: 16042104
    [Abstract] [Full Text] [Related]

  • 16. Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis.
    Gabbott M, Cossart YE, Kan A, Konopka M, Chan R, Rose BR.
    J Clin Microbiol; 1997 Dec 21; 35(12):3098-103. PubMed ID: 9399501
    [Abstract] [Full Text] [Related]

  • 17. Persistence of human papillomavirus type 6e in adult multiple laryngeal papilloma and the counterpart false cord of an interferon-treated patient.
    Ogura H, Watanabe S, Fukushima K, Baba Y, Masuda Y, Fujiwara T, Yabe Y.
    Jpn J Clin Oncol; 1993 Apr 21; 23(2):130-3. PubMed ID: 8390585
    [Abstract] [Full Text] [Related]

  • 18. 2',5'-Oligoadenylate synthetase activity analysis and human papilloma virus typing as prognostic factors in patients with recurrent respiratory papillomatosis.
    Gerein V, Rastorguev E, Gerein J, Lodemann E, Pfister H, Draf W, Desloovere C.
    J Laryngol Otol; 2004 Oct 21; 118(10):750-6. PubMed ID: 15550179
    [Abstract] [Full Text] [Related]

  • 19. Molecular analysis of resistance to interferon in patients with laryngeal papillomatosis.
    Garciá-Millián R, Santos A, Perea SE, González-Cabañas R, Valenzuela C, Araña M.
    Cytokines Cell Mol Ther; 1999 Jun 21; 5(2):79-85. PubMed ID: 10515680
    [Abstract] [Full Text] [Related]

  • 20. Molecular events in the progression of recurrent respiratory papillomatosis to carcinoma.
    Lele SM, Pou AM, Ventura K, Gatalica Z, Payne D.
    Arch Pathol Lab Med; 2002 Oct 21; 126(10):1184-8. PubMed ID: 12296755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.